The impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic medication in Finland

Hanna Koskinen (), Elina Ahola (), Leena Saastamoinen (), Hennamari Mikkola () and Jaana Martikainen ()

Health Economics Review, 2014, vol. 4, issue 1, 1-10

Abstract: Reference pricing and the extension of generic substitution produced substantial savings on antipsychotic medication costs during the first year after its launch, but the intensity of the impact differed between active substances. Furthermore, our results suggest that the additional cost savings from reference pricing after prior implemented generic substitution, are comparatively low. Copyright Koskinen et al. 2014

Keywords: Reference price system; Generic substitution; Antipsychotic drugs; Segmented linear regression analysis (search for similar items in EconPapers)
Date: 2014
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
http://hdl.handle.net/10.1186/s13561-014-0009-3 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:hecrev:v:4:y:2014:i:1:p:1-10:10.1186/s13561-014-0009-3

Ordering information: This journal article can be ordered from
http://www.springer.com/journal/13561

DOI: 10.1186/s13561-014-0009-3

Access Statistics for this article

Health Economics Review is currently edited by J. Matthias Graf von der Schulenburg

More articles in Health Economics Review from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().